New Rx

Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in
adults

Shire plc's Vyvanse can now be treated not only among children but also adults.

GlaxoSmithKline gets FDA nod for combination migraine treatment

Alcon has received approval for a nasal spray for allergic rhinitis called Patanase.

Mifamurtide available through compassionate access study

The new molecular entity Intelence helps treat HIV.

FDA approves a new molecular entity, Kuvan, to treat phenylketonuria.

The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine
(Xeloda) for patients with metastic or locally advanced breast cancer.

Raltegravir, a new drug that inhibits integrase, the enzyme responsible for the insertion of HIV DNA
into human DNA, was granted accelerated approval by the FDA.

Azor (amlodipine/olmesartan medoxomil, Daiichi Sankyo) was recently approved by the FDA as a
once-daily, oral tablet containing both a calcium channel blocker and an angiotensin receptor
blocker.